You are here: All Products  > Everest Begins Commercialization of Nefecon, an IgA Nephropathy Therapy

Everest Begins Commercialization of Nefecon, an IgA Nephropathy Therapy

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products